LncRNA MSTRG.22719.16 mediates the reduction of enoxaparin sodium high-viscosity bone cement-induced thrombosis by targeting the ocu-miR-326-5p/CD40 axis
Article in Journal of Orthopaedic Surgery and Research (September 2023)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
The mechanism by which enoxaparin sodium–high-viscosity bone cement reduces thrombosis by regulating CD40 expression in endothelial cells
Article in BMC Musculoskeletal Disorders (May 2022)
Mechanism of novel enoxaparin sodium high viscosity bone cement reducing thrombosis by regulating the expression of CD40 in endothelial cells
Preprint in Research Square (March 2022)